Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-28T17:09:05.475Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment for Positive Urine Cultures in Hospitalized Adults: A Survey of Prevalence and Risk Factors in 3 Medical Centers

Published online by Cambridge University Press:  26 November 2015

Jonathan D. Grein ,
Katherine L. Kahn ,
Samantha J. Eells ,
Seong K. Choi ,
Marianne Go-Wheeler ,
Tanzib Hossain ,
Maya Y. Riva ,
Megan H. Nguyen ,
A. Rekha Murthy  and
Loren G. Miller
Jonathan D. Grein*
Affiliation:
Department of Hospital Epidemiology, Cedars-Sinai Medical Center, Los Angeles, California
Katherine L. Kahn
Affiliation:
David Geffen School of Medicine, Division of General Internal Medicine and Health Services Research, University of California–Los Angeles (UCLA), California
Samantha J. Eells
Affiliation:
Division of Infectious Diseases, Harbor-UCLA Medical Center, and Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, California UCLA Jonathan and Karin Fielding School of Public Health, Department of Epidemiology, Los Angeles, California Science 37, Los Angeles, California
Seong K. Choi
Affiliation:
Cedars-Sinai/UCLA Multicampus Fellowship Program in Infectious Diseases, Los Angeles, California
Marianne Go-Wheeler
Affiliation:
Department of Medicine, Harbor-UCLA Medical Center, Torrance, California
Tanzib Hossain
Affiliation:
Department of Medicine, Harbor-UCLA Medical Center, Torrance, California Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey
Maya Y. Riva
Affiliation:
College of Pharmacy, Western University of Health Sciences, Pomona, California
Megan H. Nguyen
Affiliation:
Division of Infectious Diseases, Harbor-UCLA Medical Center, and Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, California College of Pharmacy, Western University of Health Sciences, Pomona, California Department of Pharmacy, St. Mary Medical Center, Long Beach, California
A. Rekha Murthy
Affiliation:
Department of Hospital Epidemiology, Cedars-Sinai Medical Center, Los Angeles, California
Loren G. Miller
Affiliation:
Division of Infectious Diseases, Harbor-UCLA Medical Center, and Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, California
*
Address correspondence to Jonathan D. Grein, MD, David Geffen School of Medicine at UCLA, Department of Hospital Epidemiology, Cedars-Sinai Medical Center, 8635 W Third St, Ste 1150-West, Los Angeles, CA 90048 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

BACKGROUND

Antibiotic treatment for asymptomatic bacteriuria (ASB) is prevalent but often contrary to published guidelines.

OBJECTIVE

To evaluate risk factors for treatment of ASB.

DESIGN

Retrospective observational study.

SETTING

A tertiary academic hospital, county hospital, and community hospital.

PATIENTS

Hospitalized adults with bacteriuria.

METHODS

Patients without documented symptoms of urinary tract infection per Infectious Diseases Society of America (IDSA) criteria were classified as ASB. We examined ASB treatment risk factors as well as broad-spectrum antibiotic usage and quantified diagnostic concordance between IDSA and National Healthcare Safety Network criteria.

RESULTS

Among 300 patients with bacteriuria, ASB was present in 71% by IDSA criteria. By National Healthcare Safety Network criteria, 71% of patients had ASB; within-patient diagnostic concordance with IDSA was moderate (kappa, 0.52). After excluding those given antibiotics for nonurinary indications, antibiotics were given to 38% (62/164) with ASB. Factors significantly associated with ASB treatment were elevated urine white cell count (65 vs 24 white blood cells per high-powered field, P<.01), hospital identity (hospital C vs A, odds ratio, 0.34 [95% CI, 0.14–0.80], P =.01), presence of leukocyte esterase (5.48 [2.35–12.79], P<.01), presence of nitrites (2.45 [1.11–5.41], P=.03), and Escherichia coli on culture (2.4 [1.2–4.7], P=.01). Of patients treated for ASB, broad-spectrum antibiotics were used in 84%.

CONCLUSIONS

ASB treatment was prevalent across settings and contributed to broad-spectrum antibiotic use. Associating abnormal urinalysis results with the need for antibiotic treatment regardless of symptoms may drive unnecessary antibiotic use.

Infect. Control Hosp. Epidemiol. 2016;37(3):319–326

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 37 , Issue 3 , March 2016 , pp. 319 - 326
Copyright
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Presented in part: IDWeek; Philadelphia, Pennsylvania; October 9, 2014 (abstract 143).

References

REFERENCES

1. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. CDC website. http://www.cdc.gov/drugresistance/threat-report-2013/index.html. Accessed June 23, 2014.Google Scholar
2. Fridkin, S, Baggs, J, Fagan, R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep 2014;63:194–200.Google ScholarPubMed
3. Gandhi, T, Flanders, SA, Markovitz, E, Saint, S, Kaul, DR. Importance of urinary tract infection to antibiotic use among hospitalized patients. Infect Control Hosp Epidemiol 2009;30:193–195.Google Scholar
4. Nicolle, LE, Bradley, S, Colgan, R, Rice, JC, Schaeffer, A, Hooten, TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643–654.Google Scholar
5. Hooten, TM, Bradley, SF, Cardenas, DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines for the Infectious Diseases Society of America. Clin Infect Dis 2010;50:625–663.CrossRefGoogle Scholar
6. Dull, RB, Friedman, SK, Risoldi, ZM, Rice, EC, Starlin, RC, Destache, CJ. Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults: a systematic review. Pharmacotherapy 2014;34:941–960.Google Scholar
7. Trautner, BW, Grigoryan, L. Approach to a positive urine culture in a patient without urinary symptoms. Infect Dis Clin North Am 2014;28:15–31.Google Scholar
8. Shaughnessy, MK, Amundson, WH, Kuskowski, MA, DeCarolis, DD, Johnson, JR, Drekonja, DM. Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol 2013;34:109–116.Google Scholar
9. Silver, SA, Baillie, L, Simor, AE. Positive urine cultures: a major cause of inappropriate antimicrobial use in hospitals? Can J Infect Dis Med Microbiol 2009;20:107–111.CrossRefGoogle Scholar
10. Cope, M, Cevallos, ME, Cadle, RM, et al. Inappropriate treatment of catheter-associated asymptomatic bacteriuria in a tertiary care hospital. Clin Infect Dis 2009;48:1182–1188.CrossRefGoogle ScholarPubMed
11. Dalen, DM, Zvonar, RK, Jessamine, PG. An evaluation of the management of asymptomatic catheter-associated bacteriuria and candiduria at the Ottawa Hospital. Can J Infect Dis Med Microbiol 2005;16:166–170.Google Scholar
12. Lin, E, Bhusal, Y, Horwitz, D, Shelburne, SA, Trautner, BW. Overtreatment of enterococcal bacteriuria. Arch Intern Med 2012;172:33–38.Google Scholar
13. Ifran, N, Brooks, A, Mithoowani, S, Celetti, SJ, Main, C, Mertz, D. A controlled quasi-experimental study of an educational intervention to reduce the unnecessary use of antimicrobials for asymptomatic bacteriuria. PLOS ONE 2015;10:e0132071.Google Scholar
14. File, TM, Solomkin, JS, Cosgrove, SE. Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs. Clin Infect Dis 2011;53:S15–S22.CrossRefGoogle ScholarPubMed
15. Choosing Wisely website. www.choosingwisely.org. Accessed October 2, 2015.Google Scholar
16. Gross, PA, Patel, B. Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria. Clin Infect Dis 2007;45:1335–1337.Google Scholar
17. Catheter-associated urinary tract infection (CAUTI) event. National Healthcare Safety Network website. http://www.cdc.gov/nhsn/acute-care-hospital/CAUTI/index.html. Accessed August 30, 2013.Google Scholar
18. Chant, C, Dos Santos, CC, Saccucci, P, Smith, OM, Marshall, JC, Friedrich, JO. Discordance between perception and treatment practices associated with intensive care unit-acquired bacteriuria and funguria: a Canadian physician survey. Crit Care Med 2008;36:1158–1167.Google Scholar
19. Trautner, BW, Petersen, NJ, Hysong, SJ, Horwitz, D, Kelly, PA, Naik, AD. Overtreatment of asymptomatic bacteriuria: identifying provider barriers to evidence-based care. Am J Infect Control 2014;42:653–658.Google Scholar
20. Drekonja, DM, Abbo, LM, Kuskowski, MA, Gnadt, C, Shukla, B, Johnson, JR. A survey of resident physician’s knowledge regarding urine testing and subsequent antimicrobial treatment. Am J Infect Control 2013;41:892–896.Google Scholar
21. Gupta, K, Hooton, TM, Naber, KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103–e120.CrossRefGoogle Scholar
22. Werner, NL, Hecker, MT, Sethi, AK, Donskey, CJ. Unnecessary use of fluoroquinolone antibiotics in hospitalized patients. BMC Infect Dis 2011;11:187.Google Scholar
23. Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431–455.Google Scholar
24. Khair, HN, VanTassell, P, Henderson, JP, Warren, DK, Marschall, J, for the CDC Prevention Epicenters Program. Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria. J Hosp Infect 2013;85:183–188.Google Scholar
25. Viera, AJ, Garrett, JM. Understanding interobserver agreement: the kappa statistic. Fam Med 2005;37:360–363.Google Scholar
26. Pavese, P, Saurel, N, Labarere, J, et al. Does an educational session with an Infectious Diseases physician reduce the use of inappropriate antibiotic therapy for inpatients with positive urine culture results? A controlled before-and-after study. Infect Control Hosp Epidemiol 2009;30:596–599.Google Scholar
27. Slimings, C, Riley, TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 2014;69:881–891.Google Scholar
28. Dellit, TH, Owens, RC, McGowan, JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–177.Google Scholar